Disclaimer: The synopsis and product information provided on Alpha.MD are derived from openFDA data and are for informational purposes only. This information may not be comprehensive, accurate, or up-to-date. Clinicians should exercise their own professional judgment in interpreting and using this information, and consult the official prescribing information for the most accurate and current details.
Description
An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.
Indication and Usage
InterActive/SwishActive Implant System consists of two-piece implants for one-stage or two-stage surgical procedures. These implants are intended for use in partially and fully edentulous upper and lower jaws in support of single or multiple-unit restorations and terminal or intermediate abutment support for fixed bridgework. Implants can be indicated for immediate loading when good primary stability has been achieved and with appropriate occlusal loading. Narrow Diameter (3.2, 3.3mm) Implants: Indicated for single-tooth replacement of mandibular central and lateral incisors and maxillary lateral incisors. These implants are also indicated for multiple tooth replacements or denture stabilization. Compatibility: InterActive and SwishActive implants are prosthetically compatible with InterActive 3.0 and 3.4mm abutments and Nobel Biocare conical connection NobelActive™ NP (Narrow Platform – 3.0mm diameter) and NobelActive™ RP (Regular Platform – 3.4mm diameter) titanium abutments. InterActive 3.0 and 3.4mm abutments are prosthetically compatible with Nobel Biocare conical connection NobelActive™ NP (Narrow Platform– 3.0mm diameter) and NobelActive™ RP (Regular Platform – 3.4mm diameter) (3.5-5.0mmD, 8.5- 18mmLength) implants.
👋
No reviews yet — be the first!
100% anonymous · Verified U.S. prescribers only
(no name, NPI, or practice ever shown)
Approval History
FDA approved 2015
Includes history for all formulations of adalimumab
July 16, 2015
(Type 2 New Active Ingredient and Type 4 New Combination)
Frequently Asked Questions
How much does Humira cost without insurance?
J
John Doe
New York, US
Products:
Humira
Humira
J
John Doe
New York, US
Products:
Humira
Humira
Signup or Login to view Reps
You must have an account to view Reps detail
Already have an account? Login
There isn't any reviews posted yet. You can be the first to review the product
